Our results will provide insight for the development of a more effective strategy for RA treatment to enhance the small incremental benefits of current clinical strategies, including various anti-cytokine therapies (anti-TNF agents and IL inhibitors), immune suppressants, and disease-modifying anti-rheumatic drugs58,59. Here, TNF is linked to rheumatoid arthritis.